Tome Biosciences
Watertown, MA
Tome Biosciences is a biotechnology company that develops programmable gene insertion technology. Using CRISPR, its technologies allow them to insert any genetic sequence of any size at any location into any genome.
tome.bioCompany Details
Founded
- 2021
Employees
- Between 50 - 200 employees
Raised
- $213,000,000
Headquarters Location
- Watertown, MA
Public
- No
Acquired
- No
CEO
- Mike Lucero
Founders
- Omar AbudayyehJonathan Gootenberg
Company Collections
These are collections Tome Biosciences is a part of. Click on the collection name to view similar companies.
Tome Biosciences' Investors
Tome Biosciences' Industries
Tome Biosciences Headquarters Location
100 Talcott Avenue, Watertown, MA 02472
Total Amount Raised: $213,000,000
Tome Biosciences' Investors
Tome Biosciences Funding Rounds
Series A
$213,000,000
Series A Investors
Longwood FundGVBrukerArch Venture PartnersAndreessen HorowitzFujifilm HoldingsPolaris PartnersAlexandria Venture Investments
Funding info provided by Diffbot.
Tome Biosciences Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Tome Biosciences.